MA43465B2 - Compositions and methods for treating rheumatoid arthritis - Google Patents

Compositions and methods for treating rheumatoid arthritis

Info

Publication number
MA43465B2
MA43465B2 MA43465A MA43465A MA43465B2 MA 43465 B2 MA43465 B2 MA 43465B2 MA 43465 A MA43465 A MA 43465A MA 43465 A MA43465 A MA 43465A MA 43465 B2 MA43465 B2 MA 43465B2
Authority
MA
Morocco
Prior art keywords
rheumatoid arthritis
compositions
methods
treating rheumatoid
monotherapy
Prior art date
Application number
MA43465A
Other languages
French (fr)
Other versions
MA43465A1 (en
Inventor
Deborah Bauer
Alexander Boddy
Neil Graham
Yong Lin
Janie Parrino
Rahul Patel
Adelsberg Janet Van
Hoogstraten Hubert Van
Original Assignee
Regeneron Pharma
Sanofi Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma, Sanofi Biotechnology filed Critical Regeneron Pharma
Priority claimed from PCT/US2017/021149 external-priority patent/WO2017155990A1/en
Publication of MA43465A1 publication Critical patent/MA43465A1/en
Publication of MA43465B2 publication Critical patent/MA43465B2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne l'utilisation d'un anticorps du récepteur anti-il6 en monothérapie pour le traitement de la polyarthrite rhumatoïde et pour l'amélioration de la fonction physique et de la qualité de vie d'un sujet souffrant de polyarthrite rhumatoïde.The present invention relates to the use of an anti-il6 receptor antibody as monotherapy for the treatment of rheumatoid arthritis and for the improvement of the physical function and quality of life of a subject suffering from rheumatoid arthritis.

MA43465A 2016-05-20 2017-03-07 Compositions and methods for treating rheumatoid arthritis MA43465B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16170664 2016-05-20
PCT/US2017/021149 WO2017155990A1 (en) 2016-03-07 2017-03-07 Compositions and methods for treating rheumatoid arthritis

Publications (2)

Publication Number Publication Date
MA43465A1 MA43465A1 (en) 2019-03-29
MA43465B2 true MA43465B2 (en) 2023-01-31

Family

ID=56101289

Family Applications (1)

Application Number Title Priority Date Filing Date
MA43465A MA43465B2 (en) 2016-05-20 2017-03-07 Compositions and methods for treating rheumatoid arthritis

Country Status (1)

Country Link
MA (1) MA43465B2 (en)

Also Published As

Publication number Publication date
MA43465A1 (en) 2019-03-29

Similar Documents

Publication Publication Date Title
MA49279A (en) ANTIBODY COMPOSITIONS OPTIMIZED FOR THE TREATMENT OF EYE DISORDERS
MA40755B1 (en) Compositions comprising bacterial strains
MA40754B1 (en) Compositions comprising bacterial strains
MA41060B1 (en) Compositions comprising bacterial strains
MA55434A (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
MA41010B1 (en) Compositions comprising bacterial strains
MA53937A (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
MA44322A (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
MA42471A (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
MA43018B1 (en) Anti-pd1 antibodies and methods of use
MA44594B1 (en) Anti-ctla-4 Antibodies and Methods of Use thereof
MA38632B1 (en) Anti-transferrin receptor antibodies and methods of use
MA37946B1 (en) Use of an anti-gm-csf antibody for the treatment of rheumatoid arthritis
MX2023014841A (en) Compositions and methods for treating rheumatoid arthritis.
MA44645B1 (en) Combined treatment of an anti-cd20 antibody with a bcl-2 inhibitor and an mdm2 inhibitor
MA47221A1 (en) Monoclonal antibody to pd-l1
MA55218A (en) ESKETAMINE FOR THE TREATMENT OF DEPRESSION
MA53873A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA
MA47362A (en) ANTI-TNF ANTIBODIES, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACTIVE PSORIASIC RHEUMATISM
MA42776B1 (en) Compounds useful for inhibiting t-ror
AU2016348418A8 (en) Compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of using same
MA55490A (en) LIPOCALIN MUTEIN FOR THE TREATMENT OF ASTHMA
MA33842B1 (en) Use of 2,3-dihydroxypropyl dedkanot for the treatment of seborrheic dermatitis
MA46988A1 (en) Liquid formulation of anti-tnf alpha antibodies
MA43465B2 (en) Compositions and methods for treating rheumatoid arthritis